These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 15694026)

  • 1. [Expression and significance of epidermal growth factor receptor variant type III in hepatocellular carcinoma].
    Ou C; Wu FX; Luo Y; Cao J; Zhao YN; Yuan WP; Li Y; Su JJ
    Ai Zheng; 2005 Feb; 24(2):166-9. PubMed ID: 15694026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Expression and significance of EGF mRNA and EGFR mRNA in hepatocellular carcinoma].
    Zhao YN; Cao J; Wu FX; Ou C; Yuan WP; Mo QG; Wei W; Li Y; Su JJ; Liang AM
    Ai Zheng; 2004 Jul; 23(7):762-6. PubMed ID: 15248908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Relationship between expression of decoy receptor 3 and apoptosis in hepatocellular carcinoma].
    Chen G; Luo DZ; Wang Y; Liao ZL; Zhang MY
    Zhonghua Bing Li Xue Za Zhi; 2007 Feb; 36(2):113-7. PubMed ID: 17493386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Study of expression of CD138 and heparinase in hepatocellular carcinoma by tissue microarray].
    Lü ZL; Zhang WM; Xiao G; Zhang M; Xie D; Xu FP; Liang XJ; Bi SJ; Wen JM
    Zhonghua Bing Li Xue Za Zhi; 2006 Feb; 35(2):82-6. PubMed ID: 16630481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Expression and clinical significance of coagulate and fibrolysis factors in tissue and plasma from hepatocellular carcinoma patients].
    Zhou Q; Liang LJ; Peng BG; Zhen YY
    Ai Zheng; 2006 Nov; 25(11):1433-8. PubMed ID: 17094916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Expression and exon 3 mutation of beta-catenin in human hepatocellular carcinoma].
    Jiao Y; Ban KC; Cao J; Yue HY; Luo Y; Su JJ
    Ai Zheng; 2007 Oct; 26(10):1085-9. PubMed ID: 17927878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The monoclonal antibody CH12 augments 5-fluorouracil-induced growth suppression of hepatocellular carcinoma xenografts expressing epidermal growth factor receptor variant III.
    Jiang H; Dong Q; Luo X; Shi B; Wang H; Gao H; Kong J; Zhang J; Li Z
    Cancer Lett; 2014 Jan; 342(1):113-20. PubMed ID: 24007863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Correlation of NY-ESO-1 gene and protein expression to metastasis and clinicopathologic features of hepatocellular carcinoma].
    Zhang WM; Xiao G; Xie D; Zhang M; Guo AL; Wen JM
    Ai Zheng; 2005 May; 24(5):622-6. PubMed ID: 15890110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Post-hepatectomy survival in advanced hepatocellular carcinoma with portal vein tumor thrombosis.
    Yamamoto Y; Ikoma H; Morimura R; Shoda K; Konishi H; Murayama Y; Komatsu S; Shiozaki A; Kuriu Y; Kubota T; Nakanishi M; Ichikawa D; Fujiwara H; Okamoto K; Sakakura C; Ochiai T; Otsuji E
    World J Gastroenterol; 2015 Jan; 21(1):246-53. PubMed ID: 25574098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The expression and significance of heparanase and nm23-H1 in hepatocellular carcinoma].
    Liu Y; Chen X; Peng S; Fang H; Wu Y; Peng C; Shi L; Bai M; Xu B; Wang J; Deng G
    Zhonghua Yi Xue Za Zhi; 2002 Nov; 82(22):1553-6. PubMed ID: 12609066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Expression and clinical significance of metastasis-associated in colon cancer 1 (MACC1) in HBV-related hepatocellular carcinoma].
    Chang XJ; Wang CP; Qu JH; Lu YY; Chen Y; Bai WL; Gao XD; Hao LY; Xu GL; Wang H; Yang YP
    Zhonghua Zhong Liu Za Zhi; 2012 Oct; 34(10):748-52. PubMed ID: 23291068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Association of cellular inhibitor of apoptosis protein-2 expression with clinical outcomes of hepatocellular carcinoma].
    Bi M; Yang D; Li X; Zhong K; Liu Y; Li G; Liao X; Liu X
    Nan Fang Yi Ke Da Xue Xue Bao; 2012 Jun; 32(7):1020-5, 1030. PubMed ID: 22820591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of vascular endothelial growth factor-C in human hepatocellular carcinoma.
    Yamaguchi R; Yano H; Nakashima O; Akiba J; Nishida N; Kurogi M; Kojiro M
    J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):152-60. PubMed ID: 16706827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Increased level of Th17 cells in peripheral blood correlates with the development of hepatocellular carcinoma].
    Wang WW; Wang ZM; Liu YY; Qin YH; Shen Q
    Zhonghua Zhong Liu Za Zhi; 2010 Oct; 32(10):757-61. PubMed ID: 21163066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serine/arginine rich splicing factor 2 expression and clinic pathological features indicating a prognostic factor in human hepatocellular carcinoma patients.
    Wang P; Guo L; Li K; Ning S; Shi W; Liu Z; Chen Y
    Cancer Biomark; 2018 Feb; 21(3):681-687. PubMed ID: 29278882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistologic study on the expressions of alpha-fetoprotein and protein induced by vitamin K absence or antagonist II in surgically resected small hepatocellular carcinoma.
    Fujioka M; Nakashima Y; Nakashima O; Kojiro M
    Hepatology; 2001 Dec; 34(6):1128-34. PubMed ID: 11732002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upregulation of FAM83D affects the proliferation and invasion of hepatocellular carcinoma.
    Liao W; Liu W; Liu X; Yuan Q; Ou Y; Qi Y; Huang W; Wang Y; Huang J
    Oncotarget; 2015 Sep; 6(27):24132-47. PubMed ID: 26125229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Study on the prognostic value of hepatocyte growth factor and c-met for patients with hepatocellular carcinoma].
    Wu FS; Zheng SS; Wu LJ; Ding W; Ma ZM; Wang ZM; Teng LS; Zhao WH
    Zhonghua Wai Ke Za Zhi; 2006 May; 44(9):603-8. PubMed ID: 16784653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Talin1, a valuable marker for diagnosis and prognostic assessment of human hepatocelluar carcinomas.
    Zhang JL; Qian YB; Zhu LX; Xiong QR
    Asian Pac J Cancer Prev; 2011; 12(12):3265-9. PubMed ID: 22471464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The value of portal vein chemotherapy after radical resection in delaying intrahepatic recurrence of stage II primary hepatocellular carcinoma].
    Zhang GQ; Ge L; Ding W; Li HJ
    Ai Zheng; 2008 Dec; 27(12):1297-301. PubMed ID: 19079997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.